Leighton A Elliott, MD : Research

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma)…

Investigator

Leighton A Elliott

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS)…

Investigator

Leighton A Elliott

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All